ELDN: Eledon Pharmaceuticals Inc. Kompaniya qiymatining sof foydaga nisbati
Eledon Pharmaceuticals (ELDN) kompaniyasining kunlik narxlar grafigi innovatsiyalarga bo'lgan talab makroiqtisodiy tendentsiyalardan mustaqil bo'lgan himoyaviy biotexnologiya sektorida faoliyat yurituvchi kompaniyaning natijalarini aks ettiradi. Joriy P/E koeffitsiyenti -2.00 darajasida turibdi. Klinik sinovlar bosqichi muntazam daromad olish imkoniyatini cheklagani sababli, kompaniyaning moliyaviy holati tashqi investitsiyalarga tayanadi. O'sish istiqbollari tegoprubart preparatini transplantatsiyani saqlab qolish uchun joriy etish va immunofarmatsevtika nishasini egallashga asoslangan.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_ELDN_-_Eledon-Pharmaceuticals_-_PE-Multiple "ELDN: Eledon Pharmaceuticals Biznesning o‘zini qoplash muddati 04.07.2022 - 15.11.2026 | 👁️GURU.Markets👁️")
Eledon Pharmaceuticals, Inc (ELDN) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Eledon Pharmaceuticals|ELDN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati eledon.com|ELDN - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Eledon Pharmaceuticals Inc.|ELDN - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Eledon Pharmaceuticals|Shoshilinch likvidlik eledon.com
- foyda va bozor multiplikatorlari tafsilotlari:
ELDN - Kompaniyaning sof foydasi|Kutilayotgan foyda Eledon Pharmaceuticals|ELDN - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Eledon|ELDN - PEG multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Eledon|ELDN - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Eledon Pharmaceuticals|ELDN - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi eledon.com|ELDN - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Eledon Pharmaceuticals
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Eledon Pharmaceuticals, Inc. ELDN
Immunologik biotexnologiya sohasining yetakchisi bo'lgan Eledon Pharmaceuticals (ELDN) uchun kompaniyaning P/E vaqtlar ketma-ketligi kelgusidagi daromadlar bo'yicha bozor kutuvlarining ko'rsatkichi bo'lib xizmat qiladi. Ushbu metrika joriy aksiya narxining bir aksiya uchun sof foydaga nisbati orqali investitsiyalarning qoplanish muddatini belgilaydi. Mazkur hisob-kitob boshqaruvning yuqori malakasi va balansning likvidligini hisobga olgan holda, biznes uchun to'langan premiumni baholash imkonini beradi. Ushbu ko'rsatkichning tendentsiyasi investorlarga aktiv qiymatini transplantatsiya paytida a'zolarni himoya qilishning haqiqiy samaradorligi bilan bog'lashga yordam beradi.
Muhim raqobatchilar
P/E multiplikatori Argenx|Narx-foyda koeffitsiyenti BNTX (BioNTech Group)|ABVX (abivax.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (admabiologics.com)|Biznesning o‘zini qoplash muddati protagonist-inc.com (PTGX)|IMVT - Narxning foydaga nisbati|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Narx-foyda koeffitsiyenti|Grifols Biemat (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotechnologies|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori auriniapharma.com|Narxning foydaga nisbati BioCryst Pharmaceuticals Inc (BCRX)|Vera Therapeutics - Narx-foyda multiplikatori|P/E multiplikatori DNTH (dianthustx.com)|Pharvaris Pharma (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Biologics - P/E multiplikatori|tourmalinebio.com - Bozor narxining sof foydaga nisbati|Precigen (PGEN) - Narxning foydaga nisbati|Pharming Group - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Nektar Therapeutics Inc|UPB (Upstream Pharma) - Bozor narxining sof foydaga nisbati|P/E multiplikatori ZBIO|P/E multiplikatori immunome.com (IMNM)|P/E multiplikatori GOSS (gossamerbio.com)|Biznesning o‘zini qoplash muddati KalVista Pharma (KALV)|SEPN - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - P/E multiplikatori|ATXS (Astria Therapeutics, Inc.) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Aerovate Therapeutics - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ACRS|Kyverna Therapeutics, Inc - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati TLSA|CABA: P/E multiplikatori|Narx-foyda koeffitsiyenti Ventyx Bio|Narxning foydaga nisbati Theratechnologies, Inc.|Kapitalizatsiyaning foydaga nisbati Avalo Therapeutics AVTX|Narxning foydaga nisbati Agenus Inc. (AGEN)|Narx-foyda koeffitsiyenti Climb Bio Inc. CLYM|P/E multiplikatori ZURA (Zura Bio Ltd)|ATYR - Narx-foyda koeffitsiyenti|ADAG - Narxning foydaga nisbati|IMA - P/E multiplikatori|STTK: P/E multiplikatori|Equillium Bio (EQ) - P/E multiplikatori|CNTB (connectbiopharm.com) - P/E multiplikatori|IMUX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ATRA|P/E multiplikatori InflaRx NV (IFRX)|X4 Pharmaceuticals, Inc. (XFOR) - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori adicetbio.com ACET|Celularity - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Corp)|BRNS (Barinthus Bio) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati KZR (Kezar Life Sciences)|Narxning foydaga nisbati SAB Biotherapeutics Inc.|Akari Therapeutics Plc - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti ENLV (Enlivex Therapeutics Ltd.)|Narx-foyda koeffitsiyenti Q32 Bio Inc QTTB|Narxning foydaga nisbati geovax.com GOVX|P/E multiplikatori edesabiotech.com EDSA|iBio Corporation - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CARM (carismatx.com)|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Bolt Bio (BOLT) - P/E multiplikatori|HCWB (HCW Biologics Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Aptevo Therapeutics (APVO)|P/E multiplikatori AIM|Bozor narxining sof foydaga nisbati ADTX|P/E multiplikatori GRI (GRI Bio Corporation)|P/E multiplikatori XORTX Corp XRTX|HIND - Narxning foydaga nisbati|Revelation Biosciences (REVB) - Narx-foyda koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Scinai Immunotherapeutics Ltd (SCNI) - P/E multiplikatori|CALI (CalciMedica Inc) - P/E multiplikatori|affimed.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati allakos.com (ALLK)|P/E multiplikatori HOOKIPA Pharma, Inc. (HOOK)|IGM Biosciences Inc. - Narx-foyda koeffitsiyenti|iTeos Therapeutics, Inc. (ITOS) - Kapitalizatsiyaning foydaga nisbati|OCEA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) PLC)|THRD: P/E multiplikatori
